血小板减少和CD34表达与α颗粒缺乏在生长因子非依赖性1B首个锌指突变中解偶联
研究在四个无关家系中鉴定GFI1B C168F变异和新型剪接变异c.2520+1_2520+8delGTGGGCAC,发现破坏非DNA结合锌指1的C168F导致无α颗粒缺乏或出血症状的轻中度血小板减少,剪接变异仅伴血小板CD34表达增高而无血小板数量或形态异常,患者iPSC来源巨核细胞重现这些表型。
要点
- GFI1B C168F变异导致轻中度血小板减少,无α颗粒缺乏或出血症状。
- GFI1B剪接变异c.2520+1_2520+8delGTGGGCAC仅伴血小板CD34表达增高,无血小板数量或形态异常。
- 血小板CD34表达可能是GFI1B功能紊乱的共同特征,并可能具有诊断价值。
核心结论
- 破坏GFI1B非DNA结合锌指1与轻中度血小板减少相关,无α颗粒缺乏或出血症状,提示GFI1B突变位点具有重要表型意义。
- 血小板CD34表达似乎是GFI1B功能紊乱的共同特征,并可能具有诊断价值。
研究设计与样本
- 在四个无关家系中鉴定GFI1B C168F变异和新型GFI1B c.2520+1_2520+8delGTGGGCAC剪接变异。
- 确定表型特征、DNA结合特性和转录效应,并与GFI1B第五DNA结合锌指H294 fs突变个体比较。
- 生成患者特异性诱导多能干细胞(iPSC)来源巨核细胞以促进疾病建模。
主要发现
- 预计破坏首个非DNA结合锌指域的DNA结合GFI1B变异C168F与无α颗粒缺乏或出血症状的大血小板减少相关。
- GFI1B剪接变异c.2520+1_2520+8delGTGGGCAC产生缺乏非DNA结合锌指1和2的短GFI1B亚型,仅与血小板CD34表达增高相关,无血小板数量或形态异常。
- GFI1B抑制CD34启动子,该抑制作用被不同GFI1B锌指突变减弱,提示CD34表达失调发生在直接转录水平。
- 患者特异性iPSC来源巨核细胞重现这些观察结果。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Essentials The phenotypes of different growth factor-independent 1B (GFI1B) variants are not established. GFI1B variants produce heterogeneous clinical phenotypes dependent on the site of mutation. Mutation of the first non-DNA-binding zinc-finger causes a mild platelet and clinical phenotype. GFI1B regulates the CD34 promoter; platelet CD34 expression is an indicator of GFI1B mutation. SUMMARY: Background Mutation of the growth factor-independent 1B (GFI1B) fifth DNA-binding zinc-finger domain causes macrothrombocytopenia and α-granule deficiency leading to clinical bleeding. The phenotypes associated with GFI1B variants disrupting non-DNA-binding zinc-fingers remain uncharacterized. Objectives To determine the functional and phenotypic consequences of GFI1B variants disrupting non-DNA-binding zinc-finger domains. Methods The GFI1B C168F variant and a novel GFI1B c.2520 + 1_2520 + 8delGTGGGCAC splice variant were identified in four unrelated families. Phenotypic features, DNA-binding properties and transcriptional effects were determined and compared with those in individuals with a GFI1B H294 fs mutation of the fifth DNA-binding zinc-finger. Patient-specific induced pluripotent stem cell (iPSC)-derived megakaryocytes were generated to facilitate disease modeling. Results The DNA-binding GFI1B variant C168F, which is predicted to disrupt the first non-DNA-binding zinc-finger domain, is associated with macrothrombocytopenia without α-granule deficiency or bleeding symptoms. A GFI1B splice variant, c.2520 + 1_2520 + 8delGTGGGCAC, which generates a short GFI1B isoform that lacks non-DNA-binding zinc-fingers 1 and 2, is associated with increased platelet CD34 expression only, without quantitative or morphologic platelet abnormalities. GFI1B represses the CD34 promoter, and this repression is attenuated by different GFI1B zinc-finger mutations, suggesting that deregulation of CD34 expression occurs at a direct transcriptional level. Patient-specific iPSC-derived megakaryocytes phenocopy these observations. Conclusions Disruption of GFI1B non-DNA-binding zinc-finger 1 is associated with mild to moderate thrombocytopenia without α-granule deficiency or bleeding symptomatology, indicating that the site of GFI1B mutation has important phenotypic implications. Platelet CD34 expression appears to be a common feature of perturbed GFI1B function, and may have diagnostic utility.
引用
- Rabbolini DJ, Morel-Kopp MC, Chen Q, et al. Thrombocytopenia and CD34 expression is decoupled from α-granule deficiency with mutation of the first growth factor-independent 1B zinc finger. J Thromb Haemost. 2017. PMID: 28880435. doi:10.1111/jth.13843
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。